CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients.

CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients.

Show other versions (1)

<h4>Background</h4>COVID-19 has so far affected more than 250 million individuals worldwide, causing more than 5 million deaths. Several risk factors for severe disease have been identified, most of which coincide with advanced age. In younger individuals, severe COVID-19 often occurs in...

Full description

Bibliographic Details
Main Authors: Simone Weber, Victoria Kehl, Johanna Erber, Karolin I Wagner, Ana-Marija Jetzlsperger, Teresa Burrell, Kilian Schober, Philipp Schommers, Max Augustin, Claudia S Crowell, Markus Gerhard, Christof Winter, Andreas Moosmann, Christoph D Spinner, Ulrike Protzer, Dieter Hoffmann, Elvira D'Ippolito, Dirk H Busch
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0268530

Internet

https://doi.org/10.1371/journal.pone.0268530

Similar Items